Clinical case of long-term use of osimertinib in the treatment of EGFR mutation-positive lung adenocarcinoma
This article reviews clinical case of epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer and the usage of osimertinib for its treatment. Targeted drugs, EGFR tyrosine kinase inhibitors were approved for the treatment of non-small cell lung cancer more than 15 years...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | article |
| Language: | RU |
| Published: |
IP Habib O.N.
2020
|
| Subjects: | |
| Online Access: | https://doaj.org/article/35b34aa048204aa58f62d993ec1f67bc |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|